GC-MS Analysis and Thrombolytic Property of Methanolic Leaf Extracts of Terminalia pallida Brandis against Carrageenan Instigated Tail Thrombosis Model in Mice

ABSTRACT

Background:Several plants of Terminaliaspecies are being reported as medicinally useful. Terminalia pallidaBrandis is one of the plants of the Combretaceae family, which constitutes several pharmacologically active substances. Present work explored leaf extract’s thrombolytic property, which could serve as the superior choice for currently using drugs. Objectives:The present study primarily focused on investigating the phyto-constituents such as phenolic and flavonoid compounds in methanolic leaf extract followed by GC-MS analysis and determining the in vitro thrombin inhibition andin vivo thrombolysis activity. Materials and Methods: Swiss albino mice (total = 36) were randomly distributed into six groups (n=6). Thrombosis was instigated by injecting 40 μL of 1% carrageenan (Type-I) via the subplantar region of the right hind paw of each mouse. The plant extract was screened for its in vitro thrombin inhibitory potency. In animal studies, the size of the blood clots in mouse tails was recorded by administering the plant extracts at 100, 200 and 300 mg/kg body weight for every 24, 48 and 72 hr, respectively. Results: A dose of 200 and 300 mg/kg of the extract showed significant thrombolytic activity at 24, 48, and 72 hr (p< 0.001) in a concentration-dependent manner when correlated with the control group. A reduction in the length of blood clots (p< 0.01) was observed at 48 and 72 hr. In acute oral toxicity study, administration of leaf extract showed no mortality and no significant behavioral changes up to 2000 mg/kg dose. The GC-MS analysis explored the occurrence of about 16 eluted compounds; among these, few have been reported as medicinally useful, which accounts for the therapeutic importance of the plant.Conclusion: In conclusion, the methanolic extract ofT. pallidaBrandis leaves at 200, and 300 mg/kg showed significant inhibition of the Thrombosis in carrageenan instigated model of mice and in vitro thrombin activity.

KEYWORDS

• Carrageenan
• Heparin
• Quercetin
• Terminallia pallida Brandis
• Thrombosis

Showing references and in-text citations exactly as published.

• DOI10.5530/pres.14.1.9Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Res..

• Article · VOLUME 14, ISSUE 1Preventive Effects of Ginger Extract and Nigella sativa Oil on Anxiety and Depression Behavior in Wistar Rats Exposed to Mercuric ChlorideSabri Benkermiche, Samir Djemli, Meriem Haloui, Mohamed Lamine Bena bed, Abdelkrim Tahraoui · pp. 1–4Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 1Comparative Macroscopic and Microscopic Characterization of Raw Herbal Drugs of Abrus precatorius L. and Glycyrrhiza glabra L.Pankaj Kumar, Javaid Fayaz Lone, Sumeet Gairola · pp. 100–106Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 1Virtual Screening of Fargesin Analogs as Candidates as Inhibitors of Aedes aegypti Sterol Carrier ProteinSammya Yasmin EM De Lima, Anderson Roberto Nery Da Silva, Cíntia Emi Yanaguibashi Leal, Edilson B De Alencar Filho · pp. 12–18Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 1GC-MS analysis of Phytocomponents in the Methanol Extract of Premna latifolia RoxbRajesh Kumar, Brijesh Kumar, Ashutosh Kumar, Ajay Kumar, Manish Singh · pp. 19–23Original ArticleSame type: Article